This company is no longer active
0JDB Stock Overview
A medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Invitae Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$1.25 |
| 52 Week Low | US$0.0001 |
| Beta | 2.8 |
| 1 Month Change | 0% |
| 3 Month Change | -50.00% |
| 1 Year Change | -99.96% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JDB | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 2.1% |
| 1Y | -100.0% | -6.3% | 1.8% |
Return vs Industry: 0JDB underperformed the UK Healthcare industry which returned -24.7% over the past year.
Return vs Market: 0JDB underperformed the UK Market which returned 6.6% over the past year.
Price Volatility
| 0JDB volatility | |
|---|---|
| 0JDB Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in GB Market | 11.2% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: 0JDB's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0JDB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 1,700 | Ken Knight | www.invitae.com |
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners.
Invitae Corporation Fundamentals Summary
| 0JDB fundamental statistics | |
|---|---|
| Market cap | US$114.60k |
| Earnings (TTM) | -US$1.44b |
| Revenue (TTM) | US$481.58m |
Is 0JDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JDB income statement (TTM) | |
|---|---|
| Revenue | US$481.58m |
| Cost of Revenue | US$350.95m |
| Gross Profit | US$130.64m |
| Other Expenses | US$1.57b |
| Earnings | -US$1.44b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.03 |
| Gross Margin | 27.13% |
| Net Profit Margin | -299.14% |
| Debt/Equity Ratio | -124.7% |
How did 0JDB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/05 13:04 |
| End of Day Share Price | 2024/05/17 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Invitae Corporation is covered by 14 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raymond Myers | Benchmark Company |
| Steven Wardell | Chardan Capital Markets, LLC |
| Daniel Leonard | Credit Suisse |